Comprehensive Healthcare Systems Inc. Announces Reinstatement of Stock Trading by TSXV and Provides Disclosure Update

In This Article:

Calgary, Alberta--(Newsfile Corp. - November 21, 2024) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, announces that TSX Venture Exchange has accepted the reinstatement of trading Company's stock.

The Company expects that its shares will resume trading on the TSXV during the week of November 25th, 2024.

The Company also wishes to provide an update in several important areas.

The Company has made significant progress in aligning its cost structure to the revenue base. It will now focus on sales and marketing initiatives which will require working capital to continue to fuel its growth.

Therefore, the Company plans to raise additional capital to allow it to focus on meeting significant working capital deficiency, its obligations and invest in future growth. The Company is in the process of talking to investors and anticipates that it will be raising capital in the near future.

As previously disclosed, the Company received debt funding of $400,000 USD (approximately $540,000 CAD) with a convertible option at an agreed permissible discount to the closing price per share of the Company recorded on the day before the conversion is approved by relevant and regulatory bodies. The conversion remains subject to acceptance of the TSX Venture Exchange. This debt is unsecured and US $ 200,000 of this debt was provided by a related party.

In addition, the senior management of the Company also infused a sum of USD 262,000 to assist with some working capital requirement. This transaction remains subject to acceptance of the TSX Venture Exchange.

The Company was required to hold an annual general meeting (AGM) on or before November 30th, 2024, as per the Alberta Business Corporate Act. The Company was not able to meet this requirement on time. It has set up its special and annual general meeting on January 15th, 2025, to meet this requirement.

The Company wishes to provide disclosure on a litigation mentioned in the audited financial statements dated December 31st, 2023. A Consulting company had filed a claim against the company for non-payment of management fees. The Company determined that the claim amount was approximately USD 300,000. The Company contested that claim and is pleased to inform that plaintiff's counsel has dropped their claim. The Company does not anticipate any future liability towards the above-mentioned claim.

In 2022, the Company further discloses that it had hired Ontogeny Capital Ltd, to assist the firm in raising capital Internationally. The Company paid an upfront fee of USD 50,000. The agreement has since been terminated.